Abemaciclib combined with endocrine therapy for the adjuvant treatment of HR+, HER2-, node-positive, high-risk, early breast cancer (monarchE) - Johnston, S RD; Harbeck, N; Hegg, R; monarchE Committee Members and Investigators (J Clin Oncol, 2020)